FDA Advisory Committee Makes Recommendations on Ampligen for Chronic Fatigue Syndrome

PHILADELPHIA, Dec. 21, 2012 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (the "Company" or "Hemispherx") today announced the outcome of the meeting of the Arthritis Advisory Committee (the "AAC") of the U.S. Food and Drug Administration (the...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news